Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Access to quality, affordable health care coverage is a critical concern for communities across Colorado, and it’s an issue ...

Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump ...

New research suggests that limiting the pharmaceutical industry’s direct-to-consumer advertising could save more money than ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from the tariff wars, Maggie Fick of ...

Emily Field, head of European pharma equity research at Barclays, told Reuters that until very recently she thought tariffs on prescription drugs were not a serious threat. Now she is "getting ...